SI Rapaport

2.6k citations
46 papers · 2.0k indexed · h-index 22

SI Rapaport

46 papers receiving 1.9k citations

Peers

SI Rapaport
Comparison fields: 5 of 81
  • Hematology 1.5k
  • Internal Medicine 187
  • Rheumatology 559
  • Genetics 387
  • Immunology and Allergy 93
Replace LV Rao with:
LV Rao United States
KG Mann United States
Katsuyasu Saigo Japan
Anne Marfaing‐Koka France
Kohshi Ohishi Japan
Andrew R. Crow Canada
A. Estellés Spain
J Arvieux France
Laura L. Swystun Canada
C Korninger Austria
SI Rapaport relative to LV Rao United States LV Rao's profile →
Citations per field
00.5×1.5×
LV Rao · 1×
Citations per year

Countries citing papers authored by SI Rapaport

Since Specialization
Citations

This map shows the geographic impact of SI Rapaport's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by SI Rapaport with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites SI Rapaport more than expected).

Fields of papers citing papers by SI Rapaport

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by SI Rapaport. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by SI Rapaport. The network helps show where SI Rapaport may publish in the future.

Co-authorship network

The 23 scholars most cited alongside SI Rapaport, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with SI Rapaport Line = papers co-authored together SI Rapaport links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 199655
2
REGIONAL CEREBRAL GLUCOSE-METABOLISM AT REST AND DURING SENSORY STIMULATION IN PATIENTS WITH ALZHEIMERS-DISEASE
19953
3 199540
4 199381
5 199188
6 19907
7 19899
8 19891
9 1989119
10 198833
11 198711
12 19853
13 1985130
14 19857
15 198391
16 19835
17 198265
18 19786
19 197769
20 19773

About SI Rapaport

SI Rapaport is a scholar working on Hematology, Genetics, Internal Medicine, Rheumatology and Cardiology and Cardiovascular Medicine, having authored 46 papers that have together received 2.0k indexed citations. Recurring topics across this work include Blood Coagulation and Thrombosis Mechanisms (29 papers), Hemophilia Treatment and Research (22 papers), Platelet Disorders and Treatments (14 papers), Hemostasis and retained surgical items (6 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers), Systemic Lupus Erythematosus Research (5 papers), Blood properties and coagulation (4 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (3 papers). The work is most often cited by research in Hematology (1.5k citations), Internal Medicine (187 citations), Rheumatology (559 citations), Genetics (387 citations) and Immunology and Allergy (93 citations). SI Rapaport has collaborated with scholars based in United States. Frequent co-authors include LV Rao, SP Bajaj, CK Kasper, Uri Seligsohn, Parichart Permpikul, Ariella Zivelin, Daniel S. Fierer, Bjarne Østerud, B J Warn-Cramer and PM Sandset. Their work appears in journals such as Blood, Annals of Neurology and American Journal of Physiology-Legacy Content.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026